SRE Holdings (2980) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Sep, 2025Executive summary
Net sales rose 35.4% year-over-year to ¥10,152 million for the six months ended September 30, 2024.
Operating profit more than doubled, up 112.0% year-over-year to ¥1,289 million.
Ordinary profit increased 123.6% year-over-year to ¥1,195 million, with net income attributable to owners of parent up 80.2% to ¥663 million.
Comprehensive income grew 81.9% year-over-year to ¥720 million.
Financial highlights
Gross profit increased to ¥4,457 million from ¥3,013 million year-over-year.
Basic EPS for the period was ¥41.24, up from ¥22.76 year-over-year.
Total assets rose to ¥30,849 million from ¥24,017 million as of March 31, 2024.
Net assets increased to ¥13,197 million, with an equity ratio of 40.8%.
Cash and cash equivalents at period end were ¥2,555 million, up from ¥1,936 million a year earlier.
Outlook and guidance
Full-year net sales forecast at ¥27,000 million, up 11.5% year-over-year.
Operating profit projected at ¥3,050 million, up 37.9% year-over-year.
Net income attributable to owners of parent forecast at ¥1,850 million, up 33.2% year-over-year.
No dividend is planned for the fiscal year.
Latest events from SRE Holdings
- Record profit and revenue growth driven by AI and real estate, with strong outlook.2980
Q3 202610 Feb 2026 - Profits fell sharply, but AI and healthcare segments grew; strong 2H recovery expected.2980
Q2 202611 Nov 2025 - Sales declined and a net loss was posted, but AI Cloud & Consulting showed strong growth.2980
Q1 20268 Sep 2025 - Strong sales and profit growth driven by segment expansion and Medix acquisition.2980
Q1 20258 Sep 2025 - Sales up 12.6% but profit down 31.7%; Medix acquisition drives asset and goodwill growth.2980
Q3 20258 Sep 2025 - Strong revenue and profit growth with FY2026 guidance projecting over 30% increases.2980
Q4 20258 Sep 2025